Global Biologic Therapeutics Drugs Market Growth 2023-2029

Global Biologic Therapeutics Drugs Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Biologic Therapeutics Drugs Industry Forecast” looks at past sales and reviews total world Biologic Therapeutics Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologic Therapeutics Drugs sales for 2023 through 2029. With Biologic Therapeutics Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic Therapeutics Drugs industry.

This Insight Report provides a comprehensive analysis of the global Biologic Therapeutics Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologic Therapeutics Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologic Therapeutics Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic Therapeutics Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic Therapeutics Drugs.

The global Biologic Therapeutics Drugs market size is projected to grow from US$ 315410 million in 2022 to US$ 481660 million in 2029; it is expected to grow at a CAGR of 481660 from 2023 to 2029.

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic Therapeutics Drugs market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics

Segmentation by application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biologic Therapeutics Drugs market?

What factors are driving Biologic Therapeutics Drugs market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biologic Therapeutics Drugs market opportunities vary by end market size?

How does Biologic Therapeutics Drugs break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.